Viewing Study NCT00117234


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-04-12 @ 7:09 PM
Study NCT ID: NCT00117234
Status: COMPLETED
Last Update Posted: 2010-12-03
First Post: 2005-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Impact of Darbepoetin Alfa on Exercise Tolerance and Left Ventricular Structure in Subjects With Symptomatic Congestive Heart Failure (CHF) and Anemia
Sponsor: Amgen
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 20020126
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Global Development Leader
Old Organization: Amgen Inc.

Collaborators